UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2290746-2290746

2024

Volltextzugriff (PDF)

Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment

Haematologica (Roma), 2024-03, Vol.109 (3), p.963

2024

Volltextzugriff (PDF)

Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis

American journal of respiratory and critical care medicine, 2008-12, Vol.178 (11), p.1180-1185

2008

Volltextzugriff (PDF)

P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL

HemaSphere, 2023-08, Vol.7 (S3), p.e371346c-n/a

2023

Volltextzugriff (PDF)

Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.52-59

2010

Volltextzugriff (PDF)

P1473: CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB‐ANALYSIS OF THE ACTIVATE TRIAL

HemaSphere, 2023-08, Vol.7 (S3), p.e918756f-n/a

2023

Volltextzugriff (PDF)

P1479: COMORBIDITIES AND COMPLICATIONS IN ADULTS WITH PYRUVATE KINASE DEFICIENCY ACCORDING TO HEMOGLOBIN STRATA – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

HemaSphere, 2023-08, Vol.7 (S3), p.e7441867-n/a

2023

Volltextzugriff (PDF)

Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy, 2009-09, Vol.53 (9), p.3981-3984

2009

Volltextzugriff (PDF)

Next Generation Sequencing for the Diagnosis of Hereditary Hemolytic Anemias Including Pyruvate Kinase Deficiency: Report from a No-Cost Diagnostic Program

Blood, 2022-11, Vol.140 (Supplement 1), p.2436-2437

2022

Volltextzugriff (PDF)

The Launch of Two Sub-Studies of the Peak Registry, a Global, Longitudinal Study of Pyruvate Kinase Deficiency

Blood, 2022-11, Vol.140 (Supplement 1), p.11041-11042

2022

Volltextzugriff (PDF)

Comorbidities and Complications in Pediatric Patients with Pyruvate Kinase Deficiency Enrolled in the Peak Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.5316-5318

2022

Volltextzugriff (PDF)

Age of Onset of Complications in Patients with Pyruvate Kinase Deficiency: Analysis from the Peak Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.5323-5325

2022

Volltextzugriff (PDF)

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry

British journal of haematology, 2024-08, Vol.205 (2), p.613-623

2024

Volltextzugriff (PDF)

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Blood, 2021-11, Vol.138 (Supplement 1), p.2005-2005

2021

Volltextzugriff (PDF)

Characterizing Iron Overload By Age in Patients Diagnosed with Pyruvate Kinase Deficiency - a Descriptive Analysis from the Peak Registry

Blood, 2021-11, Vol.138 (Supplement 1), p.3074-3074

2021

Volltextzugriff (PDF)

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Blood, 2022-11, Vol.140 (Supplement 1), p.5313-5315

2022

Volltextzugriff (PDF)

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Blood, 2021-11, Vol.138 (Supplement 1), p.924-924

2021

Volltextzugriff (PDF)

Tuberculosis pharmacotherapy: strategies to optimize patient care

Expert opinion on pharmacotherapy, 2009-02, Vol.10 (3), p.381-401

2009

Volltextzugriff (PDF)

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing

Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10), p.e02193-17

2018

Volltextzugriff (PDF)

HIV Pharmacology: Barriers to the Eradication of HIV from the CNS

HIV clinical trials, 2006-05, Vol.7 (3), p.142-153

2006

Volltextzugriff (PDF)

Reconceptualizing the Policy Subsystem: Integration with Complexity Theory and Social Network Analysis

Policy studies journal, 2019-05, Vol.47 (S1), p.S138-S158

2019

Volltextzugriff (PDF)

The effect of preoperative tamsulosin on ureteroscopic access in school-aged children

Journal of pediatric urology, 2021-12, Vol.17 (6), p.795.e1-795.e6

2021

Volltextzugriff (PDF)

The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning

Journal of magnetic resonance imaging, 2024-01

2024

Volltextzugriff (PDF)

Exploring Indigenous Ways of Coping After a Wildfire Disaster in Northern Alberta, Canada

Qualitative health research, 2021-07, Vol.31 (8), p.1472-1485

2021

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency

Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment

Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis

P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL

Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda

P1473: CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB‐ANALYSIS OF THE ACTIVATE TRIAL

P1479: COMORBIDITIES AND COMPLICATIONS IN ADULTS WITH PYRUVATE KINASE DEFICIENCY ACCORDING TO HEMOGLOBIN STRATA – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY

Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis

Next Generation Sequencing for the Diagnosis of Hereditary Hemolytic Anemias Including Pyruvate Kinase Deficiency: Report from a No-Cost Diagnostic Program

The Launch of Two Sub-Studies of the Peak Registry, a Global, Longitudinal Study of Pyruvate Kinase Deficiency

Comorbidities and Complications in Pediatric Patients with Pyruvate Kinase Deficiency Enrolled in the Peak Registry

Age of Onset of Complications in Patients with Pyruvate Kinase Deficiency: Analysis from the Peak Registry

Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry

Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency

Characterizing Iron Overload By Age in Patients Diagnosed with Pyruvate Kinase Deficiency - a Descriptive Analysis from the Peak Registry

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Tuberculosis pharmacotherapy: strategies to optimize patient care

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing

HIV Pharmacology: Barriers to the Eradication of HIV from the CNS

Reconceptualizing the Policy Subsystem: Integration with Complexity Theory and Social Network Analysis

The effect of preoperative tamsulosin on ureteroscopic access in school-aged children

The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning

Exploring Indigenous Ways of Coping After a Wildfire Disaster in Northern Alberta, Canada

Suchergebnisse filtern